Identification and validation of plasma protein biomarkers as therapeutic targets in acute myeloid leukemia: an integrative multi-omics study.

Front Immunol · 2025 · PMC12586143 · PMID 41200167

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

We identified proteins that were nominally significant in at least two analyses and aligned in direction in three analyses as potential causal biomarkers.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.